Alvarado v. Teva Pharmaceuticals, USA Inc. et al
Consolidated
Lead case: 1:20-md-02974
Lead case: 1:20-md-02974
| Georgia Northern District Court | |
| Judge: | Leigh Martin May |
| Case #: | 1:23-cv-06004 |
| Nature of Suit | 367 Torts - Personal Injury - Health Care/Pharmaceutical Personal Injury/Product Liability |
| Cause | 28:1332 Diversity-Personal Injury |
| Case Filed: | Dec 28, 2023 |
| Terminated: | Dec 28, 2023 |
| Case in other court: | New Jersey, 2:23-cv-22991 |
| Last checked: Saturday Jun 29, 2024 5:41 AM EDT |
|
Defendant
Cooper Companies, Inc.
|
Represented By
|
|
Defendant
Cooper Surgical Inc
|
Represented By
|
|
Defendant
Teva Pharmaceutical R&D, Inc.
|
Represented By
|
|
Defendant
Teva Pharmaceuticals USA, Inc.
|
Represented By
|
|
Defendant
Teva Women's Health, Inc.
|
Represented By
|
|
Defendant
Teva Women's Health, LLC
|
Represented By
|
|
Plaintiff
Nancy Alvarado
|
Represented By
|
| Docket last updated: 01/26/2025 11:59 PM EST |
| Friday, November 15, 2024 | ||
| 9 | 9
2
pgs
order
Order
Mon 11/18 7:48 PM
ORDER: Defendants' Consent Motion to Revise Leadership Structure for MDL Proceedings, Doc. No. 731, is GRANTED. Therefore, the Clerk is directed to substitute Kasey M. Adams, Esq., for Tara L. Blake, Esq., as Co-Lead Counsel for the Cooper Defendants in this action and in all associated cases. (Second Copy of 732 in 1:20-md-02974-LMM. Entered in member cases 1:22-cv-1028 through 3:20- cv-194.) Signed by Judge Leigh Martin May on 11/15/2024. (tht) |
|
| 8 | 8
1
pgs
order
Order
Mon 11/18 1:35 PM
ORDER granting (730 in 1:20-md-02974-LMM) Tara L. Blake's unopposed motion to withdraw as counsel of record for Defendants CooperSurgical, Inc. and The Cooper Companies, Inc. Signed by Judge Leigh Martin May on 11/15/2024. (Second Copy of 732 in 1:20-md-02974-LMM. Entered in member cases 1:22-cv-1028 through 3:20-cv-194.) (bgt) |
|
| Wednesday, March 20, 2024 | ||
| 7 | 7
service
Waiver of Service Executed
Wed 03/20 1:07 PM
WAIVER OF SERVICE Returned Executed by Nancy Alvarado. Cooper Companies, Inc. waiver mailed on 2/14/2024, answer due 4/15/2024; Cooper Surgical Inc waiver mailed on 2/14/2024, answer due 4/15/2024; Teva Pharmaceutical R&D, Inc. waiver mailed on 2/26/2024, answer due 4/26/2024; Teva Pharmaceuticals USA, Inc. waiver mailed on 2/26/2024, answer due 4/26/2024; Teva Women's Health, LLC waiver mailed on 2/26/2024, answer due 4/26/2024.(Galpern, Michael) |
|
|
Att: 1
Exhibit Executed Waiver of the Service of Summons,
|
||
|
Att: 2
Exhibit Executed Waiver of the Service of Summons,
|
||
|
Att: 3
Exhibit Executed Waiver of the Service of Summons,
|
||
|
Att: 4
Exhibit Executed Waiver of the Service of Summons,
|
||
|
Att: 5
Exhibit Executed Waiver of the Service of Summons
|
||
| Thursday, January 25, 2024 | ||
| 6 | 6
cmp
Amended Complaint
Thu 01/25 9:24 AM
First AMENDED COMPLAINT against Cooper Companies, Inc., Cooper Surgical Inc, TEVA PHARMACEUTICAL R & D, INC., Teva Pharmaceuticals USA Inc, Teva Women's Health LLC, Teva Women's Health, Inc. d/b/a Teva Women's Health, LLCwith Jury Demand filed by NANCY ALVARADO.(Galpern, Michael) |
|
|
Att: 1
Civil Cover Sheet
|
||
| Tuesday, January 02, 2024 | ||
|
utility
Remark
Tue 01/02 9:34 AM
Remark: Counsel should review all Orders docketed in MDL Case No. 1:20-md-2974-LMM. The Court's Case Management Orders and other case-related documents can also be found on the Court's MDL web page: https://www.gand.uscourts.gov/20md2974 (bnp) |
||
| Thursday, December 28, 2023 | ||
| 5 | 5
6
pgs
order
Order
Thu 12/28 1:14 PM
ORDER INITIAL CONFERENCE: The Court held its Initial Conference in this MDL on February 9, 2021. The below are the orders entered after discussion of these issues at that conference. 1. Leadership structure: After the Court discussed issues concerning the leadership structure with all parties, the Court ORDERED Plaintiffs and Defendants to each file their proposed consent motion and order as to their requested leadership structure and team within 7 days of the date of this order. 2. Future status conferences: The Court will hold status conferences once a month. The next six conferences will take place on the following dates at 10:00 am via zoom: Tuesday, March 9, 2021; Monday, April 12, 2021; Wednesday, May 12, 2021; Monday, June 14, 2021; Tuesday, July 13, 2021; Friday, August 20, 2021. The Court will send out the zoom links prior to the conferences. The parties will submit a proposed consent agenda 3 business days prior to the conference. The parties will also confer as to the format for presenting issues that require additional explanation. When these are necessary, they should also be filed 3 business days before the conference. 3. Stay of responsive pleading obligations: The Court continues the stay of responsive pleading obligations provided for in Section 6(b) of the Court's initial order. 4. Pending motions: The Court DENIES WITHOUT PREJUDICE all pending motions in the individual cases comprising the MDL. These cases are also ADMINISTRATIVELY CLOSED. These terminated motions will later be refiled in accordance with an upcoming Case Management Order. 5. Docketing: All parties are to docket future filings only in the MDL case. The case caption should indicate whether any filing applies to all cases or list the individual cases to which it should apply. 6. Electronic service: The Court ORDERS all attorneys participating in the MDL proceeding to register with the Court's CM/ECF system. Because all attorneys will then receive electronic copies of documents filed in the MDL, the Court ORDERS that electronic service of documents via the Court's CM/ECF system satisfies the obligation of service. Hereafter, unless otherwise ordered, neither the clerk's office nor counsel for the parties shall be obligated to provide service copies of any filings or related orders by U.S. Mail or any other means to attorneys who have not registered with the Court's CM/ECF system. An attorney who is not participating in the MDL and does not want to receive CM/ECF notifications may file a motion to withdraw or a certificate of consent to withdraw in accordance with Local Rule 83.1(E). 7. Initial disclosures: The Court GRANTS the parties' joint request for the Court to excuse the parties from Rule 26(f) initial disclosures; except as to the ParaGard New Drug Application (NDA) that was transferred on or about November 10, 2005, to Duramed Pharmaceuticals, Inc., and produced by TWH, Inc., to plaintiff in the Estrada case. 8. Case management and initial orders: The parties are ORDERED to confer as to proposed orders for the list found herein. See order for further specifics and instructions. Signed by Judge Leigh Martin May on 02/10/2021. (tht) |
|
| 4 | 4
transfer
Case Transferred In - District Transfer
Thu 12/28 12:07 PM
Case transferred in from District of New Jersey; Case Number 2:23-cv-22991. Original file certified copy of transfer order and docket sheet received. |
|
| 3 | 3
2
pgs
order
Order
Thu 12/28 11:16 AM
Order of MDL Panel transferring case to the Northern District of Georgia. (krg) [Transferred from New Jersey on 12/28/2023.] |
|
|
utility
Terminate Civil Case
Thu 12/28 1:22 PM
Civil Case Terminated. (tht) |
||
| Friday, December 15, 2023 | ||
| 2 | 2
SUMMONS ISSUED as to COOPER COMPANIES, INC., COOPER SURGICAL, INC., TEVA PHARMACEUTICAL R & D, INC., TEVA PHARMACEUTICALS, USA, INC., TEVA WOMEN'S HEALTH, INC. d/b/a TEVA WOMEN'S HEALTH, LLC, TEVA WOMEN'S HEALTH, LLC. Attached is the official court Summons, please fill out Defendant and Plaintiffs attorney information and serve. (sm) [Transferred from New Jersey on 12/28/2023.]
|
|
| CLERK'S QUALITY CONTROL MESSAGE - Please be advised, pursuant to Fed. R. Civ. P. 7.1(a)(2), unless the Court orders otherwise, in any action filed or removed to this Court, in which jurisdiction is based upon diversity under 28 U.S.C. 1332(a), a party or intervenor must file a disclosure statement naming and identifying the citizenship of every individual or entity whose citizenship is attributed to that party or intervenor. A party, intervenor or proposed intervenor must file the disclosure statement with its first appearance, pleading, petition, motion, response, or other request addressed to the Court.[LINK:Click here] to complete the Diversity Disclosure Statement, once complete, file it using the event Diversity Disclosure Statement. (sm) [Transferred from New Jersey on 12/28/2023.] | ||
| Monday, December 11, 2023 | ||
| 1 | 1
COMPLAINT against COOPER COMPANIES, INC., COOPER SURGICAL, INC., TEVA PHARMACEUTICAL R & D, INC., TEVA PHARMACEUTICALS, USA, INC., TEVA WOMEN'S HEALTH, INC. d/b/a TEVA WOMEN'S HEALTH, LLC, TEVA WOMEN'S HEALTH, LLC ( Filing and Admin fee $ 405 receipt number ANJDC-14931216) with JURY DEMAND, filed by Nancy Alvarado.(GALPERN, MICHAEL) [Transferred from New Jersey on 12/28/2023.]
|
|
|
Att: 1
Civil Cover Sheet
|
||
| Case Assigned to Judge Madeline Cox Arleo and Magistrate Judge Jose R. Almonte. (ak, ) [Transferred from New Jersey on 12/28/2023.] | ||